Amgen has 'a lot to prove' in the weight-loss drug category, says Mizuho's Jared Holz
0
0
09/02/24
Jared Holz, Mizuho, joins 'Closing Bell Overtime' to talk Amgen's obesity drug trial results.
להראות יותר
0 הערות
sort מיין לפי
